Toggle light / dark theme

What if “looking your age” refers not to your face, but to your chest? Osaka Metropolitan University scientists have developed an advanced artificial intelligence (AI) model that utilizes chest radiographs to accurately estimate a patient’s chronological age. More importantly, when there is a disparity, it can signal a correlation with chronic disease.

These findings mark a leap in , paving the way for improved early disease detection and intervention. The results are published in The Lancet Healthy Longevity.

The research team, led by graduate student Yasuhito Mitsuyama and Dr. Daiju Ueda from the Department of Diagnostic and Interventional Radiology at the Graduate School of Medicine, Osaka Metropolitan University, first constructed a deep learning-based AI model to estimate age from chest radiographs of healthy individuals.

Researchers at the Francis Crick Institute have found that molecules in vegetables like broccoli or cauliflower help to maintain a healthy barrier in the lung and ease infection.

The AHR—aryl hydrocarbon receptor—is a protein found at barrier sites like the gut and the lung. Natural molecules in cruciferous vegetables—for example, kale, cauliflower, broccoli, or cabbage—are dietary ‘ligands’ for AHR, which means, once eaten, they activate AHR to target a number of genes. Some of the genes targeted switch off the AHR system, allowing it to self-regulate.

The effect of AHR on is well understood, but this research, published in Nature, now shows that AHR is also highly active in lining in the lung.

Remember when eggs were so high? A vaccine for birds, now that can make money. 🤔

In the past two years, a viral disease has swept across much of the planet — not Covid but a type of avian flu. It’s devastated the poultry industry in the US, Europe, and elsewhere, sickening millions of farmed birds, which either die from infection or are killed by farmers seeking to stem the spread.


The ongoing outbreak of avian flu has killed hundreds of thousands — if not millions — of wild birds, including endangered species like the California condor. It’s one of the worst wildlife disease outbreaks in history. Having now spread across five continents and hundreds of wildlife species, scientists call the current outbreak a panzootic, meaning a pandemic among animals.

“What we’re seeing right now is uncharted territory,” said Andrew Ramey, a wildlife geneticist at the US Geological Survey, one of the federal agencies involved in testing wild birds for the virus.

The number of dead birds in itself is historic, but so is the virus’s biology. Typically, avian influenza viruses only cause severe disease and death in domestic birds like chickens and farmed ducks; they sweep through populations, killing upward of 90 percent of the flock.

Scientists have found that bubbles secreted by embryonic stem cells counter cellular senescence, in large part due to just two tiny snippets of RNA [1].

Extracellular vesicles (EVs) are membrane-bound tiny bubbles that are loaded with various molecular cargo, such as proteins, DNA, or RNA, that cells secrete as a method of intercellular communication. According to numerous studies, EVs can recapitulate many effects of cellular therapies, such as stem cell treatments [2].

In this new study, the researchers used EVs derived from human embryonic stem cells (ESC) against cellular senescence. ESCs are considered a potent therapeutic, tool but, as the study’s authors note in the introduction, their use “is limited by immune rejection, tumorigenicity and ethical issues”. If we could culture ESCs and use EVs secreted by them to the same effect, this would solve many problems.

Researchers have developed a fluorescence microscope that uses structured illumination for fast super-resolution imaging over a wide field of view. The new microscope was designed to image multiple living cells simultaneously with a very high resolution to study the effects of various drugs and mixtures of drugs on the body.

“Polypharmacy—the effect of the many combinations of drugs typically prescribed to the chronically sick or elderly—can lead to dangerous interactions and is becoming a major issue,” said Henning Ortkrass from Bielefeld University in Germany. “We developed this microscope as part of the EIC Pathfinder OpenProject DeLIVERy, which aims to develop a platform that can investigate polypharmacy in individual patients.”

In the journal Optics Express, the researchers describe their new microscope, which uses optical fiber delivery of excitation light to enable very high image quality over a very large field of view with multicolor and high-speed capability. They show that the instrument can be used to image , achieving a field of view up to 150 × 150 μm2 and imaging rates up to 44 Hz while maintaining a spatiotemporal resolution of less than 100 nm.

Stem cells have been used to produce organoids that release the proteins responsible for forming dental enamel, a substance that shields teeth from harm and decay. This initiative was led by a multi-disciplinary team of researchers from the University of Washington in Seattle.

“This is a critical first step to our long-term goal to develop stem cell-based treatments to repair damaged teeth and regenerate those that are lost,” said Hai Zhang, professor of restorative dentistry at the UW School of Dentistry and one of the co authors of the paper describing the research.

The findings are published today in the journal Developmental Cell. Ammar Alghadeer, a graduate student in Hannele Ruohola-Baker’s laboratory in the Department of Biochemistry at the UW School of Medicine was the lead author on the paper. The lab is affiliated with the UW Medicine Institute for Stem Cell and Regenerative Medicine.

A recent study study sheds light on how a protein called amyloid precursor protein (APP) affects the growth of nerve cells in the cortex — the human brain’s outer layer. The findings suggest that APP plays a crucial role in maintaining the delicate balance between neural stem cell proliferation and differentiation during the early stages of brain development.

The research, published in Science Advances, could have important implications for our understanding of neurodevelopmental processes and neurodegenerative diseases.

APP is a class I transmembrane protein that is widely expressed during nervous system development. It has been extensively studied due to its connection to Alzheimer’s disease (AD), where its fragmentation produces amyloid peptides that contribute to neuronal death. However, the physiological function of APP, especially in the context of human brain development, has remained unclear.

A team of scientists recently aimed to better understand consciousness and its pathologies by studying the neural activity of patients with disorders of consciousness and healthy volunteers using brain imaging technology. They identified two crucial brain circuits implicated in consciousness. The results of the study have been published in Human Brain Mapping.

Consciousness is a complex and subjective experience, and there is still much debate among scientists and philosophers about its nature and origin. However, in clinical settings, doctors treating patients with severe brain injuries and disorders of consciousness need to find ways to help their patients, regardless of the exact definition of consciousness. The authors of the new study sought to better understand the mechanisms behind the pathological loss of consciousness and its recovery, as well as to have reliable ways to assess the state of the patients.

“In recent years, many studies have tried to objectively assess levels of consciousness using various neuroimaging techniques. While these studies have improved how we diagnose patients with disorders of consciousness, they haven’t fully explained how consciousness comes about,” explained study author Jitka Annen, a postdoctoral researcher at the Coma Science Group at the University of Liege.